Fortis Healthcare Limited - Laporan Laba Rugi (TTM)

Fortis Healthcare Limited
IN ˙ NSEI ˙ INE061F01013
₹ 948.00 ↓ -2.05 (-0.22%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Fortis Healthcare Limited menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 38,825 38,906 40,301 48,345 53,023 55,920 57,176 57,952 59,398 60,330 62,976 64,672 66,299 67,497 68,974 70,944 73,128 75,614 77,861 80,939
Change (%) 0.21 3.59 19.96 9.68 5.46 2.25 1.36 2.50 1.57 4.39 2.69 2.52 1.81 2.19 2.86 3.08 3.40 2.97 3.95
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 17,242 17,316 19,582 22,835 25,187 26,693 24,923 25,638 26,638 27,315 26,779 28,003 29,039 29,927 41,977 44,886 45,809 47,039 32,005 33,467
Change (%) 0.43 13.09 16.61 10.30 5.98 -6.63 2.87 3.90 2.54 -1.96 4.57 3.70 3.06 40.27 6.93 2.06 2.68 -31.96 4.57
% of Revenue 44.41 44.51 48.59 47.23 47.50 47.74 43.59 44.24 44.85 45.28 42.52 43.30 43.80 44.34 60.86 63.27 62.64 62.21 41.10 41.35
Gross Operating Profit 21,583 21,590 20,719 25,510 27,836 29,226 32,253 32,314 32,760 33,015 36,197 36,669 37,260 37,571 39,735 26,058 27,320 28,576 45,857 47,473
Change (%) 0.03 -4.04 23.12 9.12 4.99 10.36 0.19 1.38 0.78 9.64 1.30 1.61 0.83 5.76 -34.42 4.84 4.60 60.47 3.52
% of Revenue 55.59 55.49 51.41 52.77 52.50 52.26 56.41 55.76 55.15 54.72 57.48 56.70 56.20 55.66 57.61 36.73 37.36 37.79 58.90 58.65
SG&A 2,447 2,447 1,322 1,322 1,322 1,322 2,302 2,302 2,302 2,302 3,084 3,084 3,084 3,084 3,417 3,417 3,417 3,417 4,152 4,152
Change (%) 0.00 -45.98 0.00 0.00 0.00 74.14 0.00 0.00 0.00 33.99 0.00 0.00 0.00 10.79 0.00 0.00 0.00 21.50 0.00
% of Revenue 6.30 6.29 3.28 2.73 2.49 2.36 4.03 3.97 3.88 3.82 4.90 4.77 4.65 4.57 4.95 4.82 4.67 4.52 5.33 5.13
R&D
Change (%)
% of Revenue
OpEx 38,859 38,637 39,119 43,389 46,426 48,376 49,573 50,604 51,889 53,004 55,132 56,664 58,091 59,255 59,780 61,208 62,455 64,134 65,915 67,617
Change (%) -0.57 1.25 10.92 7.00 4.20 2.48 2.08 2.54 2.15 4.02 2.78 2.52 2.00 0.89 2.39 2.04 2.69 2.78 2.58
% of Revenue 100.09 99.31 97.07 89.75 87.56 86.51 86.70 87.32 87.36 87.86 87.54 87.62 87.62 87.79 86.67 86.28 85.40 84.82 84.66 83.54
Operating Income -34 269 1,183 4,955 6,597 7,544 7,603 7,347 7,509 7,326 7,844 8,008 8,208 8,242 9,251 9,736 10,673 11,480 11,946 13,323
Change (%) -897.28 338.98 319.01 33.12 14.35 0.78 -3.36 2.20 -2.44 7.07 2.09 2.50 0.41 12.25 5.24 9.63 7.56 4.05 11.52
% of Revenue -0.09 0.69 2.93 10.25 12.44 13.49 13.30 12.68 12.64 12.14 12.46 12.38 12.38 12.21 13.41 13.72 14.60 15.18 15.34 16.46
Interest Expense -1,550 -1,492 -1,408 -1,381 -1,364 -1,323 -1,194 -1,121 -1,046 -999 -1,005 -1,008 -998 -994 -936 -974 -1,020 -1,142 -1,421 -1,764
Change (%) -3.78 -5.63 -1.88 -1.26 -2.96 -9.79 -6.06 -6.72 -4.48 0.60 0.29 -0.98 -0.41 -5.84 4.04 4.74 11.95 24.40 24.14
% of Revenue -3.99 -3.83 -3.49 -2.86 -2.57 -2.37 -2.09 -1.94 -1.76 -1.66 -1.60 -1.56 -1.51 -1.47 -1.36 -1.37 -1.39 -1.51 -1.82 -2.18
Net Income -3,037 -1,974 -1,098 3,327 4,435 5,303 5,551 4,138 5,113 5,241 5,887 5,782 5,476 5,527 5,989 6,531 6,558 7,690 7,742 8,685
Change (%) -34.98 -44.41 -403.12 33.29 19.58 4.68 -25.45 23.56 2.51 12.32 -1.78 -5.30 0.93 8.36 9.05 0.42 17.27 0.67 12.18
% of Revenue -7.82 -5.07 -2.72 6.88 8.36 9.48 9.71 7.14 8.61 8.69 9.35 8.94 8.26 8.19 8.68 9.21 8.97 10.17 9.94 10.73

Source: Capital IQ

Other Listings
IN:532843
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista